Prytime Medical™ Devices, Inc. Launches STAAR (Simulation Trainer for Arterial Access and REBOA) to Support Global Training
The Prytime Medical™ STAAR offers clinically accurate conditions for arterial access training and ER-REBOA™ Catheter placement.
SAN ANTONIO, August 22, 2019 /PRNewswire-PRWeb/ -- Prytime Medical Devices Inc., today announced the launch of the Prytime Medical STAAR (Simulation Trainer for Arterial Access and REBOA). During hemorrhage control, time and survival are closely related. Therefore, arterial access and catheter placement training is essential to improve speed and precision; this is an important part of any ER-REBOA program.
"Simulation training has become a critically important tool for surgical skills training, particularly with procedures such as REBOA, said Dr. Bradley Dennis, Associate Professor of Surgery at Vanderbilt University Medical Center. "Advancements in simulation technology have permitted surgical teams to learn, practice and improve their skills for use in real-life situations. They now have the ability to teach ultrasound-guided common femoral artery (CFA) cannulation on simulators with pulsatile perfusion designed specifically for REBOA training."
The Prytime Medical STAAR consists of a pulsatile flow loop that simulates a patient's blood pressure and flow, as well as an ultrasound compatible access patch to visualize key anatomy such as the common femoral artery for arterial access training. This state-of-the-art simulator allows surgeons/interventionalists, nurses, and technicians the ability to learn and master critical skills to improve procedural efficiency and outcomes.
The Prytime Medical STAAR will be used in many on-going training programs, including: ACS COT BEST™ Courses and Workshops, The RAPToR Course, EVTM Workshops, Denver Health's Advanced Endovascular Skills for Trauma Surgeons and the Vanderbilt Fellows Program.
"Prytime Medical looks forward to our continued partnership with program directors of these dynamic training programs who also believe the sooner you stop bleeding the better," David Spencer, President and Chief Executive Officer of Prytime Medical Devices.
About Prytime Medical™ Devices, Inc.
Prytime Medical™ Devices, Inc. designs, develops and commercializes minimally invasive solutions for hemorrhage control. We are proud to be a part of bringing military medical innovation to the civilian marketplace. We believe no one should bleed to death. The sooner you stop bleeding the better. The underlying intellectual property for the ER-REBOA™ Catheter was conceived by experienced military vascular and trauma surgeons, COL. Todd Rasmussen and Dr. Jonathan Eliason, based on lessons learned on the battlefront during combat.
About REBOA
Resuscitative Endovascular Balloon Occlusion of the Aorta is a minimally invasive technique using a balloon catheter to temporarily occlude large vessels in support of hemorrhage control. In trauma, hemorrhage is the leading cause of potentially survivable death: Non-compressible truncal hemorrhage is of particular interest, because there are limited clinical options to temporarily occlude large vessels during truncal hemorrhage. Similarly, clinicians report REBOA use in other emergent hemorrhage control situations, such as postpartum hemorrhage, adjunct during surgical procedures, interventional radiology and pre-hospital settings.
SOURCE Prytime Medical
Share this article